Rebecca Byam - 29 Aug 2021 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Financial Officer
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact for Rebecca A. Byam
Issuer symbol
HCWB
Transactions as of
29 Aug 2021
Net transactions value
$0
Form type
4
Filing time
10 Sep 2021, 17:52:18 UTC
Previous filing
10 Sep 2021
Next filing
26 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCWB Stock Option (Right to Buy) Award $0 +135,000 $0.000000 135,000 29 Aug 2021 Common Stock 135,000 $4.00 Direct F1
transaction HCWB Stock Option (Right to Buy) Award $0 +80,000 $0.000000 80,000 08 Sep 2021 Common Stock 80,000 $4.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest as follows: 33% will vest on July 22, 2022, 33% will vest on July 22, 2023 and 34% will vest on July 22, 2024.
F2 The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025.